Last year at this time, it was not uncommon for firms to ink 20 or more deals in a month to fund U.S.-based startups. In October only two firms — Y...
Health, Wellness & Biotech
Fourteen companies joined The Crunchbase Unicorn Board in October as late-stage funding plummeted worldwide.
Not New York City was in the tech spotlight in a big way last month. We look at other deals in the region.
Emalex Biosciences, a biotech startup, announced it raised $250 million in Series D funding led by Bain Capital.
Human Immunology Biosciences, a clinical-stage biotech company, emerged from stealth armed with $120 million. The company was developed by Monograph...
Funding rounds were smaller in October, as cleantech and energy saw big raises, but biotech played a starring role as investors kept the faith.
Crunchbase data shows funding around health record startups is at $367 million, the highest it’s been since 2021, and 2022 isn’t over yet.
Teletherapy funding surpassed $1.4 billion worldwide so far in 2022, a huge spike from past years, according to Crunchbase data.
Once upon a time not that long ago, fintech, cybersecurity and crypto would dominate this list. This week, the top three rounds were raised by a...
Few of the record 143 biotech startups that made their public debut last year had a product to sell. We unpack the odd nature of biotech IPOs.
While there are plenty of startups in the drug manufacturing world, very few (if any) have been able to approach the problem through designing...
![Illustration of a blue unicorn with a green money background. [Dom Guzman]](https://news.crunchbase.com/wp-content/uploads/Unicorn_Money_v3-300x168.jpg)
![Illustration of data method. [Li-Anne Dias]](https://news.crunchbase.com/wp-content/uploads/data_method-300x168.jpg)
![Illustration of conversation bubbles. [Dom Guzman]](https://news.crunchbase.com/wp-content/uploads/Talk-300x168.jpg)
67.1K Followers